Chai Discovery
San Francisco, California, United States · Artificial Intelligence, Biotechnology, Health Care
Chai Discovery is the developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. The company's platform operates models that can predict the structure of biochemical molecules and reprogram how they interact for developing new medications, enabling researchers to get unified prediction
Key facts
- Headquarters
- San Francisco, California, United States
- Employees
- 36
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- www.chaidiscovery.com
- Company page
Recent activity at Chai Discovery
- : Chai Discovery Partners with GSK to Enhance Drug Discovery Following Successful Technology Evaluation. (date Fundz recorded it)
- : Chai Discovery secures $400M in Series C funding to enhance AI-driven molecular design. The round was led by Index Ventures with participation from several notable investors.
- : Chai Discovery Signs License Agreement with Pfizer to Enhance AI in Drug Discovery. (date Fundz recorded it)
- : Chai Discovery partners with Eli Lilly to enhance biologics discovery using AI technology. (date Fundz recorded it)
- : Chai Discovery secures $130M in Series B funding led by Oak HC/FT and General Catalyst to advance AI drug design.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Chai Discovery funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Series C | $400.0M |
| Dec 2025 | Series B | $130.0M |
Leadership
- Jack Dent, Founder
- Joshua Meier, Founder
- Matthew McPartlon, Founder
Verified email and direct lines for Chai Discovery’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Chai Discovery files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Chai Discovery in the news
- Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery - Business Wire (Jan 09, 2026)
- Chai Discovery Announces $70M Series A To Transform Molecular Design - AI Insider (Aug 12, 2025)
- RushDATA™: AI-Ready Data for Models and Agents with 1-Day CHO Expression - The Scientist (Oct 29, 2026)
- Chai Discovery Announces Collaboration with Roche in AI-Driven Drug Discovery - Business Wire (Nov 05, 2026)
- Chai-1 Released by Chai Discovery Team: A Groundbreaking Multi-Modal Foundation Model Set to Transform Drug Discovery and Biological Engineering with Revolutionary Molecular Structure Prediction - MarkTechPost (Sep 10, 2024)
- Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery - Business Wire (Aug 20, 2026)
- Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI - Business Wire (Jun 02, 2026)
- Chai Discovery Announces $400M Series C to Advance AI-Driven Molecular Design - Business Wire (Jul 14, 2026)
Companies similar to Chai Discovery
- Respiree · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
- Ryght · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
- Blackford Analysis · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
- Odysight.ai · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
About Chai Discovery: questions and answers
What does Chai Discovery do?
Chai Discovery is the developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. The company's platform operates models that can predict the structure of biochemical molecules and reprogram how they interact for developing new medications, enabling researchers to get unified prediction
Where is Chai Discovery headquartered?
Chai Discovery is headquartered in San Francisco, California, United States.
How many employees does Chai Discovery have?
Chai Discovery has about 36 employees.
Has Chai Discovery raised funding?
Yes. Fundz has recorded 2 funding events for Chai Discovery. The most recent, Series C of $400.0M, was in Jul 2026.
Who leads Chai Discovery?
Jack Dent is a Founder at Chai Discovery.
What is the latest news on Chai Discovery?
On Oct 9, 2026, Chai Discovery Partners with GSK to Enhance Drug Discovery Following Successful Technology Evaluation.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy